Raaj Medisafe India Limited
BSE: RAAJMEDI · Packaging
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Raaj Medisafe India Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Raaj Medisafe India Limited is an Indore-based manufacturer specialising in sterile single-use hypodermic syringes and needles. The company also operates a secondary business segment producing aluminium crown caps and closures for the beverage and pharmaceutical industries.
Business Model
The company generates revenue through the sale of medical disposables and industrial closures, serving both institutional clients and retail distributors. It leverages automated precision manufacturing to maintain compliance with international safety standards.
Growth Outlook
Growth is driven by the expansion of production capacity and the strengthening of distribution networks to meet rising domestic demand for affordable medical consumables. The company aims to leverage its dual-segment expertise to maintain its niche position in the Indian healthcare infrastructure market.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving international safety standards for medical device manufacturing.
- Market Competition. Intense competition within the medical disposables sector may exert pressure on profit margins and market share.
- Input Cost Volatility. Fluctuations in the prices of raw materials, such as aluminium and medical-grade plastics, could impact operational profitability.
- Institutional Dependency. Reliance on government hospital contracts introduces risks related to tender cycles and payment delays.
Start your research today
Unlock AI insights, financials, peers and live data on Raaj Medisafe India Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹80 Cr
TTM · standalone
NET PROFIT
₹8 Cr
TTM · standalone
EPS
₹5.83
TTM · standalone
RETURN ON EQUITY
26.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
19.6%
TTM · standalone
P/E
16.9x
Q4 FY26 · standalone
EV/EBITDA
17.2x
Q4 FY26 · standalone
EBITDA MARGIN
15.4%
TTM · standalone
NET PROFIT MARGIN
12.9%
Q4 FY26 · standalone
DEBT TO EQUITY
1.4x
Q4 FY26 · standalone
Peers · Packaging
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Raaj Medisafe India LimitedRAAJMEDI | ₹160 Cr | 16.89 | 17.16 | 28.2% | 15.4% | 26.1% | 19.6% | — |
Shri Jagdamba Polymers LimitedSHRJAGP | ₹554 Cr | 13.43 | 6.42 | — | 19.8% | 13.3% | 22.2% | -19.2% |
TPL PlastechTPLPLASTEH | ₹524 Cr | 17.85 | 10.90 | 25.9% | 10.9% | 19.0% | 25.3% | -4.6% |
B&B Triplewall Containers LimitedBBTCL | ₹474 Cr | 3.54 | 6.57 | 19.9% | 16.6% | 26.6% | 26.1% | +15.7% |
HCP Plastene Bulkpack LimitedHPBL | ₹422 Cr | 9.16 | 7.56 | 31.3% | 13.5% | 56.5% | 55.0% | +100.7% |
Cropster AgroCROPSTER | ₹217 Cr | 1.58 | 14.81 | 105.9% | 7.1% | 12.7% | 13.4% | -88.3% |
As of Q4 FY26
Financials
Raaj Medisafe India Limited
BSE: RAAJMEDI · Packaging
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Raaj Medisafe India Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Raaj Medisafe India Limited is an Indore-based manufacturer specialising in sterile single-use hypodermic syringes and needles. The company also operates a secondary business segment producing aluminium crown caps and closures for the beverage and pharmaceutical industries.
Business Model
The company generates revenue through the sale of medical disposables and industrial closures, serving both institutional clients and retail distributors. It leverages automated precision manufacturing to maintain compliance with international safety standards.
Growth Outlook
Growth is driven by the expansion of production capacity and the strengthening of distribution networks to meet rising domestic demand for affordable medical consumables. The company aims to leverage its dual-segment expertise to maintain its niche position in the Indian healthcare infrastructure market.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving international safety standards for medical device manufacturing.
- Market Competition. Intense competition within the medical disposables sector may exert pressure on profit margins and market share.
- Input Cost Volatility. Fluctuations in the prices of raw materials, such as aluminium and medical-grade plastics, could impact operational profitability.
- Institutional Dependency. Reliance on government hospital contracts introduces risks related to tender cycles and payment delays.
Start your research today
Unlock AI insights, financials, peers and live data on Raaj Medisafe India Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹80 Cr
TTM · standalone
NET PROFIT
₹8 Cr
TTM · standalone
EPS
₹5.83
TTM · standalone
RETURN ON EQUITY
26.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
19.6%
TTM · standalone
P/E
16.9x
Q4 FY26 · standalone
EV/EBITDA
17.2x
Q4 FY26 · standalone
EBITDA MARGIN
15.4%
TTM · standalone
NET PROFIT MARGIN
12.9%
Q4 FY26 · standalone
DEBT TO EQUITY
1.4x
Q4 FY26 · standalone
Peers · Packaging
As of Q4 FY26